SYNAGIS
SYNAGIS
Discontinued
DIN Number
02245889
Drug Class
Human
Market Date
Sep 26, 2002
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02245889
AIG Number0147401001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
J06BD01 PALIVIZUMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular
AHFS Classification08:18.24
Health Canada Classification
ACTIVE INGREDIENTS (1)
PALIVIZUMABActive
Strength: 50 MG / VIAL
Monograph: PALIVIZUMAB